Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Charles Matouk

Neurological Surgery New Haven, CT Medical Doctor

NPI 1053696187 CMS profile 93020

800 Howard Ave, Lower Level, Neuroscience Center, New Haven, CT 06519

Open in the dashboard

General payments

$113,503

166 records reported · program years 2019–2025

Research payments

$17,417

Paid to them · 10 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$1,216,670 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Charles Matouk of New Haven, CT is reported in the CMS Open Payments database as having received $113,503 across 166 general payments and $17,417 in research payments paid to them. Separately, studies naming them as principal investigator received $1,216,670 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 92nd percentile of Neurological Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $39,410 28
2025 Research $800 1
2024 General $15,152 28
2023 General $991 10
2022 General $33,896 34
2021 General $20,327 34
2021 Research $16,617 9
2019 General $3,727 32

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Charles Matouk
  • Neurological Surgery median
  • Middle half of Neurological Surgery
  • National median

In program year 2025, general payments to Charles Matouk were reported at $39,410. Among 5,467 Neurological Surgery profiles paid that year, the median was $596 and the middle half received between $159 and $3,102.

Show as a table
Year Charles Matouk Neurological Surgery median Middle half National median
2019 $3,727 $582 $138–$3,006 $163
2020 $0 $294 $76–$2,174 $114
2021 $20,327 $387 $105–$2,432 $132
2022 $33,896 $542 $139–$2,989 $149
2023 $991 $534 $145–$2,697 $160
2024 $15,152 $574 $155–$3,046 $164
2025 $39,410 $596 $159–$3,102 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Silk Road Medical, Inc. $51,983 63 payments
  2. Medical Device Business Services, Inc. $26,027 12 payments
  3. Penumbra, Inc. $24,496 29 payments
  4. MicroVention, Inc. $5,476 26 payments
  5. Aesculap, Inc. $1,987 2 payments
  6. Medtronic USA, Inc. $817 7 payments
  7. DePuy Synthes Sales Inc. $472 5 payments
  8. Boston Scientific Corporation $340 2 payments
  9. Siemens Medical Solutions USA, Inc. $336 4 payments
  10. Medtronic, Inc. $326 6 payments
  11. Other $1,244 10 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $54,520 11 payments
  2. Travel and Lodging $30,694 55 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $19,800 6 payments
  4. Food and Beverage $8,489 94 payments
Products named General payments · program years 2019–2025
  1. ENROUTE Transcarotid Stent $51,139 53 payments
  2. ENROUTE Transcarotid Neuroprotection System Cardiology/Vascular Diseases $51,139 53 payments
  3. Penumbra System $22,511 15 payments
  4. Spotlight $16,060 2 payments
  5. ENHANCE Transcarotid Peripheral Access Kit $15,827 21 payments
  6. ENROUTE .014 Guidewire $15,827 21 payments
  7. LVIS JUNIOR $1,991 3 payments
  8. PROGAV 2.0 $1,875 1 payment
  9. ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter $1,781 3 payments
  10. ENROUTE Transcarotid Neuroprotection System Cardiology/Vascular Diseases $1,781 3 payments
  11. Other $12,485 110 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. MicroVention, Inc. $16,617 9 payments
  2. Medtronic, Inc. $800 1 payment

Billing to Medicare

Part B · data year 2024 · 58 billing codes

Paid by Medicare

$173,065

Medicare's payments for the services billed

Medicare patients

271

Average age 76

Services billed

786

147 women, 124 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 55%
Ischemic heart disease 40%
Depression 36%
Diabetes 32%
Atrial fibrillation 28%
Chronic kidney disease 25%
Cancer 24%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

176 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record